Le Lézard
Classified in: Health
Subject: MAT

US Fertility hosts Fall Fertility Week featuring 8 free events for the 1 in 8 experiencing infertility


US Fertility is excited to offer a series of free virtual events and Instagram Live sessions from November 7-11, 2022, to help individuals and couples make progress toward their goal of building a family.

ROCKVILLE, Md., Nov. 3, 2022   /PRNewswire-PRWeb/ -- US Fertility partner practices proudly host Fall Fertility Week from November 7-11, 2022, complete with 8 free, virtual patient education events. Over the course of 5 days, US Fertility physicians will host webinars and Instagram Live sessions featuring topics like fertility treatments, menstrual cycles, fertility health, endometriosis, polycystic ovary syndrome (PCOS), and LGBTQ+ family-building, among others. Each event concludes with a live question-and-answer session where attendees will have the opportunity to have their questions answered live by US Fertility physicians.

"It can feel daunting to manage fertility testing and treatments. There is strength in knowing that you are not alone; 1 in 8 people is faced with infertility," shares Caleb Kallen, M.D. Ph.D., who sees patients at SGF's Philadelphia, Pennsylvania, location, and who will host the in vitro fertilization (IVF) webinar on November 11 at 12 p.m. EST. "Fall Fertility Week is intended to build a sense of community for those facing the challenges posed by infertility. The events provide attendees with the information they need to confidently pursue their family-building goals."    

US Fertility is the largest network of physician-owned and physician-led fertility practices in the nation. With more than 130,000 babies born to its credit, US Fertility completes more than 30,000 fresh IVF cycles annually, nearly 70,000 cycles total, including frozen embryo transfers, and performs 1,000+ elective and donor egg freezing cycles annually. US Fertility partner practices include Fertility Centers of Illinois (FCI), IVF FLORIDA, Reproductive Science Center of the San Francisco Bay Area (RSC), and Shady Grove Fertility (SGF).

Interested attendees are welcome to join as many Fall Fertility Week events as they desire, even if they cannot attend the live presentation. All registrants will receive a recording of each event via email to view at their convenience.

Fall Fertility Week 2022 events at-a-glance

Monday, November 7, 2022 @ 1 p.m. EST| Fertility Health Instagram Live | Allison Rogers, M.D., FCI physician

Tuesday, November 8, 2022 @ 12 p.m. EST | Fertility 101 Webinar and Q&A | Valerie Libby, M.D. M.P.H., SGF physician

Tuesday November 8, 2022 @ 4 p.m. EST | Egg Freezing Instagram Live | Channing Burks Chatmon, M.D., FCI physician

Wednesday, November 9, 2022 @ 3 p.m. EST | Menstrual Cycle Webinar and Q&A | Quinton Katler, M.D., M.Sc., SGF physician

Thursday, November 10, 2022 @ 3 p.m. EST | PCOS Webinar and Q&A | Evan Rosenbluth, M.D., RSC physician

Thursday, November 10, 2022 @ 5 p.m. EST | LGBTQ+ Family Building Instagram Live | Eduardo Hariton, RSC physician

Friday November 11, 2022 @ 12 p.m. EST| IVF Webinar and Q&A | Caleb Kallen, M.D., Ph.D., SGF physician

Friday, November 11, 2022 @ p.m. EST | Endometriosis Instagram Live | Daniel R. Christie, M.D., IVF FLORIDA physician

While US Fertility webinars are complimentary, interested parties must register to attend by visiting the calendar of events.

About US Fertility?
US Fertility is the nation's largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit?USFertility.com.?

Media Contact

Jean Dzierzak, US Fertility, 301-545-1375, [email protected]

 

SOURCE US Fertility


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: